Allergy

Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.

Dupilumab therapy for 4 weeks in adults with severe atopic dermatitis resulted in significant improvements in clinical outcomes with no adverse events reported.

The first and only drug to treat peanut allergy recently received approval, giving the growing number of patients a new treatment option.

Sample: The hygiene hypothesis states that early exposure to germs reduces the immune system’s ability to resist infections in later years. True or false?

How do we combat waning human immunity? Our slide show summarizes 5 new reports that suggest it’s essential to figure that out.

Where do US guidelines on immunotherapy for rhinitis overlap with new 2018 recommendations from Europe? Answer these 5 questions to find out.

Try this compact test on safety issues of and patieint selection for seasonal allergy medications.